XML 39 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Equity-Based Compensation [Abstract]  
Schedule of Management Contingent Share Plan The following table summarizes the Management Contingent Share Plan activity for the year ended December 31, 2022:
   Management
Contingent
Share Plan
   Grant Date
Fair Value
 
Beginning of year   
-
   $
-
 
Granted   9,200,000   $7.81 
Forfeited   (3,683,000)  $7.81 
End of year   5,517,000   $7.81 
Vested   1,169,000   $7.81 
Schedule of Stock Option Activity The following table summarizes stock option activity under the 2020 Plan for the year ended December 31, 2022:
   Stock
Option
Awards
   Weighted-
Average
Exercise
Price
   Average
Remaining
Life
(Years)
   Aggregate
Intrinsic
Value
 
Beginning of year   2,828,307   $6.51                       
Granted   204,181   $15.75           
Exercised   (14,796)  $6.51           
Forfeited   (252,593)  $8.36           
End of year   2,765,099   $7.02    2.77   $
-
 
Exercisable at end of year   2,480,991   $6.70    2.67   $
-
 
Schedule of Fair Value of Stock Option is a Black-Scholes The table below illustrates the weighted-average valuation assumptions used for stock options granted during the year ended December 31, 2022 and 2021:
   2022   2021 
Expected term (years)   3.2    2.3 
Expected volatility   70.0%   94.3%
Risk-free interest rate   1.38%   0.24%
Expected dividend yield   0.0%   0.0%
Per-share weighted average grant date fair value  $15.75   $0.59 
Schedule of Equity-Based Compensation Expense Equity-based compensation expense, excluding the Management Contingent Share Plan, was recorded in the following expense categories within the consolidated statements of operations consistent with the manner in which the respective employee or service provider’s related cash compensation was recorded:
   2022   2021 
Research and development1  $110   $(19)
Selling, general and administrative   834    150 
Total equity based compensation expense  $944   $131 
1)Had the Company recorded the Management Contingent Share Plan within research and development and selling, general and administrative expense, then research and development would have been higher by $201 with the remaining expense recognized within selling, general and administrative expense.